Bio-Medical Applications Of New Hampshire Inc Exeter, NH - 03833

Bio-Medical Applications Of New Hampshire Inc is categorized under Kidney Dialysis Centers in Exeter, NH .

Bio-Medical Applications Of New Hampshire Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.

If you are seeking more information, feel free to contact Allison Jenks at the company’s branch by writing to 1 Hampton Road Unit 109, Exeter, New Hampshire NH 03833 or by phoning (603) 777-9931. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bio-Medical Applications Of New Hampshire Inc
Contact Person: Allison Jenks
Address: 1 Hampton Road Unit 109, Exeter, New Hampshire 03833
Phone Number: (603) 777-9931
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Kidney Dialysis Centers
SIC Code: 8092
NAICS Code: 621492
Share This Business:

Bio-Medical Applications Of New Hampshire Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Allison Jenks for inquiries that concern Bio-Medical Applications Of New Hampshire Inc by calling the company number (603) 777-9931, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of New Hampshire Inc can be found at the coordinates 42.977822,-70.9178 as well as the street address 1 Hampton Road Unit 109 in Exeter, New Hampshire 03833.

For its online presence, you may visit Bio-Medical Applications Of New Hampshire Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.